Keyphrases
COVID-19
100%
United Kingdom
44%
Virus
28%
SARS-CoV-2 Infection
17%
Ebola Virus
15%
Healthcare Workers
14%
Wales
14%
Ebola Virus Disease
14%
Confidence Interval
14%
Crimean-Congo Hemorrhagic Fever Virus (CCHFV)
14%
Vaccination
13%
Tuberculosis
13%
Europe
12%
Quantitative PCR
11%
Whole Genome Sequencing
11%
Public Health England
11%
Epidemiology
10%
Clinical Characterization
10%
Neutralizing Antibodies
9%
Surveillance System
9%
Influenza
9%
Antibody Response
9%
Crimean-Congo Hemorrhagic Fever
9%
Sierra Leone
9%
Emerging Infections
9%
Risk Factors
8%
Severe Acute Respiratory Syndrome
8%
Zika Virus
8%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
8%
SARS-CoV-2 Variants
8%
Hospital Admission
7%
World Health Organization
7%
Mycobacterium Tuberculosis (M. tb)
7%
Seroprevalence
7%
Monkeypox Virus
7%
Patients with COVID-19
7%
Travellers
7%
COVID-19 Cases
7%
Migrants
7%
Vaccine Effectiveness
7%
Transmissibility
7%
Legionnaires' Disease
7%
Variants of Concern
6%
Infectious Diseases
6%
Unvaccinated
6%
Serology
6%
Hospitalization
6%
Platform Trials
6%
Laboratory Confirmation
6%
Primary Care
6%
Public Health
6%
Influenza-like Illness
5%
Contact Tracing
5%
T Cell Response
5%
Multicenter Cohort Study
5%
Fever
5%
Nucleocapsid Protein
5%
ISARIC
5%
Alpha Variant
5%
COVID-19 Pandemic
5%
Odds Ratio
5%
Prospective Cohort Study
5%
Virus Infection
5%
Severe Disease
5%
Delta Variant
5%
Active Tuberculosis
5%
Household Transmission
5%
Care Homes
5%
Immune Response
5%
Immunogenicity
5%
Medicine and Dentistry
COVID-19
71%
Infection
65%
Severe Acute Respiratory Syndrome Coronavirus 2
62%
Diseases
32%
Public Health
30%
Virus
17%
Cohort Analysis
15%
Virus Infection
13%
Ebolavirus
13%
Cohort Effect
10%
Observational Study
10%
Prevalence
10%
Pathogen
10%
Primary Health Care
8%
Prospective Cohort Study
7%
Systematic Review
7%
Health Care
7%
Odds Ratio
6%
Crimean-Congo Hemorrhagic Fever
6%
Cohort Study
6%
Whole Genome Sequencing
6%
Cross Sectional Study
6%
Pontiac Fever
5%
Antibody Response
5%
Household
5%
Surveillance System
5%
Serotype
5%
Intensive Care Unit
5%
Intensive Care
5%